Biogen manufactures the drug Skyclarys, which has received approvals from both the EMA and the FDA. The company is also dealing with a high court challenge regarding a delay, while the HSE Drugs Group considers coverage.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Biogen manufactures the drug Skyclarys, which has received approvals from both the EMA and the FDA. The company is also dealing with a high court challenge regarding a delay, while the HSE Drugs Group considers coverage.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Fianna Fáil is demanding funding for access to the drug Skyclarys.Sub-event
- EMA approved a drug for patient use, prompting the National Centre for Pharmacoeconomics to demand price reduction and TDs to urge reimbursement.Sub-event
Biogen's Skyclarys receives EMA/FDA approval amid high court challenge and market access considerations.1 source
Keep exploring
The entities involved
-
Biogen
American multinational biotechnology company
Nothing else this week.